200 related articles for article (PubMed ID: 24965695)
1. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.
Roerink SH; Wagenmakers MA; Wessels JF; Sterenborg RB; Smit JW; Hermus AR; Netea-Maier RT
Pituitary; 2015 Jun; 18(3):366-75. PubMed ID: 24965695
[TBL] [Abstract][Full Text] [Related]
2. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
[TBL] [Abstract][Full Text] [Related]
3. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acromegaly improves quality of life, measured by AcroQol.
Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
[TBL] [Abstract][Full Text] [Related]
5. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
[TBL] [Abstract][Full Text] [Related]
6. Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
Chin SO; Chung CH; Chung YS; Kim BJ; Kim HY; Kim IJ; Kim JG; Kim MS; Kim SY; Lee EJ; Lee KY; Kim SW
BMJ Open; 2015 Jun; 5(6):e006898. PubMed ID: 26063564
[TBL] [Abstract][Full Text] [Related]
7. Total score or subscales in scoring the acromegaly quality of life questionnaire: using novel confirmatory methods to compare scoring options.
Felt JM; Depaoli SA; Pereira AM; Biermasz NR; Tiemensma J
Eur J Endocrinol; 2015 Jul; 173(1):37-42. PubMed ID: 25872514
[TBL] [Abstract][Full Text] [Related]
8. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
Hua SC; Yan YH; Chang TC
Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
[TBL] [Abstract][Full Text] [Related]
10. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
Webb SM; Badia X; Surinach NL;
Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
[TBL] [Abstract][Full Text] [Related]
11. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
[TBL] [Abstract][Full Text] [Related]
12. Impact of cosmetic facial surgery on satisfaction with appearance and quality of life.
Litner JA; Rotenberg BW; Dennis M; Adamson PA
Arch Facial Plast Surg; 2008; 10(2):79-83. PubMed ID: 18347233
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment on quality of life in patients with acromegaly: a prospective study.
Wolters TLC; Roerink SHPP; Sterenborg RBTM; Wagenmakers MAEM; Husson O; Smit JWA; Hermus ARMM; Netea-Maier RT
Eur J Endocrinol; 2020 Mar; 182(3):319-331. PubMed ID: 31958318
[TBL] [Abstract][Full Text] [Related]
14. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
[TBL] [Abstract][Full Text] [Related]
15. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly.
Imran SA; Tiemensma J; Kaiser SM; Vallis M; Doucette S; Abidi E; Yip CE; De Tugwell B; Siddiqi F; Clarke DB
Eur J Endocrinol; 2016 Jan; 174(1):41-50. PubMed ID: 26586838
[TBL] [Abstract][Full Text] [Related]
16. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
[TBL] [Abstract][Full Text] [Related]
17. Appearance-related psychosocial distress following facial skin cancer surgery using the FACE-Q Skin Cancer.
Vaidya TS; Mori S; Dusza SW; Rossi AM; Nehal KS; Lee EH
Arch Dermatol Res; 2019 Nov; 311(9):691-696. PubMed ID: 31338583
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
[TBL] [Abstract][Full Text] [Related]
19. Acromegaly in remission: a view from the partner.
Fourneaux R; Vermalle M; Albarel F; Morange I; Graillon T; Amodru V; Cuny T; Dufour H; Brue T; Castinetti F
Eur J Endocrinol; 2021 Oct; 185(6):K19-K23. PubMed ID: 34586080
[TBL] [Abstract][Full Text] [Related]
20. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.
Wassenaar MJ; Biermasz NR; Kloppenburg M; van der Klaauw AA; Tiemensma J; Smit JW; Pereira AM; Roelfsema F; Kroon HM; Romijn JA
Growth Horm IGF Res; 2010 Jun; 20(3):226-33. PubMed ID: 20194043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
